Hengliang Wang

Title: Innovations and Contributions of Hengliang Wang

Introduction

Hengliang Wang is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of immunogenic proteins and recombinant fusion proteins. With a total of three patents to his name, Wang's work has the potential to impact vaccine development and infectious disease treatment.

Latest Patents

Hengliang Wang's latest patents include an immunogenic protein and its composition and application. This invention discloses an immunogenic protein comprising 39 amino acids from the N-terminal α-helix part of the Ata protein transport functional domain. The amino acid sequence of these 39 amino acids is shown as the 127-165 amino acid residues of SEQ ID NO:2. The invention also describes a method for preparing a bacterial polysaccharide-modified recombinant fusion protein. This method involves co-expressing a recombinant fusion protein and the O-oligosaccharyltransferase PglL in a gene-defective bacterium, linking polysaccharides to the recombinant fusion protein. This protein can be utilized for preparing antibodies against bacterial polysaccharides and vaccines.

Career Highlights

Hengliang Wang has worked at prestigious institutions such as the Institute of Biotechnology, Academy of Military Medical Sciences, China, and Chengdu Olymvax Biopharmaceuticals Inc. His experience in these organizations has allowed him to develop innovative solutions in the field of biopharmaceuticals.

Collaborations

Wang has collaborated with notable colleagues, including Jun Wu and Chao Pan. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hengliang Wang's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in immunology and vaccine development.